Homology Medicines Probability of Future Stock Price Finishing Over 1.09
| FIXXDelisted Stock | USD 1.09 0.06 5.83% |
Homology |
Homology Medicines Target Price Odds to finish over 1.09
The tendency of Homology Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.09 | 90 days | 1.09 | about 6.43 |
Based on a normal probability distribution, the odds of Homology Medicines to move above the current price in 90 days from now is about 6.43 (This Homology Medicines probability density function shows the probability of Homology Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Homology Medicines has a beta of 0.93. This usually indicates Homology Medicines market returns are sensitive to returns on the market. As the market goes up or down, Homology Medicines is expected to follow. Additionally Homology Medicines has an alpha of 0.0368, implying that it can generate a 0.0368 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Homology Medicines Price Density |
| Price |
Predictive Modules for Homology Medicines
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Homology Medicines. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Homology Medicines' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Homology Medicines Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Homology Medicines is not an exception. The market had few large corrections towards the Homology Medicines' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Homology Medicines, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Homology Medicines within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.04 | |
β | Beta against Dow Jones | 0.93 | |
σ | Overall volatility | 0.07 | |
Ir | Information ratio | 0.01 |
Homology Medicines Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Homology Medicines for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Homology Medicines can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Homology Medicines is now traded under the symbol QTTB. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Homology Medicines is not yet fully synchronised with the market data | |
| Homology Medicines has some characteristics of a very speculative penny stock | |
| Homology Medicines has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.16 M. Net Loss for the year was (112.96 M) with loss before overhead, payroll, taxes, and interest of (95.14 M). | |
| Homology Medicines currently holds about 201.07 M in cash with (96.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.5, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Homology Medicines Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Homology Stock often depends not only on the future outlook of the current and potential Homology Medicines' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Homology Medicines' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 57.8 M | |
| Cash And Short Term Investments | 82.7 M |
Homology Medicines Technical Analysis
Homology Medicines' future price can be derived by breaking down and analyzing its technical indicators over time. Homology Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Homology Medicines. In general, you should focus on analyzing Homology Stock price patterns and their correlations with different microeconomic environments and drivers.
Homology Medicines Predictive Forecast Models
Homology Medicines' time-series forecasting models is one of many Homology Medicines' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Homology Medicines' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Homology Medicines
Checking the ongoing alerts about Homology Medicines for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Homology Medicines help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Homology Medicines is now traded under the symbol QTTB. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Homology Medicines is not yet fully synchronised with the market data | |
| Homology Medicines has some characteristics of a very speculative penny stock | |
| Homology Medicines has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.16 M. Net Loss for the year was (112.96 M) with loss before overhead, payroll, taxes, and interest of (95.14 M). | |
| Homology Medicines currently holds about 201.07 M in cash with (96.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.5, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in Homology Stock
If you are still planning to invest in Homology Medicines check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Homology Medicines' history and understand the potential risks before investing.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |